UBS Global Healthcare Conference 2025 November 10, 2025 3:30 PM ESTCompany ParticipantsDave Gancarz - Chief Business ...
Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
Survival World on MSN
Hunter Analyzed 500,000 Deer To Predict The Best Days To Hunt This Rut Season
The DeerBrain host plotted 10 years of statewide harvest and looked for the dreaded dead zone near peak breeding. He says it ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that our partner, Akeso, Inc. ("Akeso, ...
A study shows that genome-wide association studies (GWAS) and rare variant burden tests highlight different disease genes.
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company developing therapies to target hypertension and related comorbidities such as chronic kidney disease (CKD), ...
Q3 2025 Management View President and CEO Punit Dhillon reported that recent data from the Phase IIa CB1 study has "sharpened our focus, maintained our focus on our clinical path and strengthened our ...
Objectives Neurogranin (Ng) has a role in synaptic plasticity and is considered a biomarker of synaptic dysfunction, a process hypothesised to be important in delirium. Few studies examining Ng in ...
Objective This study aimed to assess the prevalence of eye care service utilisation and associated factors among healthcare professionals in Gondar city, northwest Ethiopia. Design An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback